HEADER HYDROLASE/ANTIBIOTIC 17-DEC-10 3Q1F TITLE CTX-M-9 S70G IN COMPLEX WITH HYDROLYZED PIPERACILLIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EXTENDED-SPECTRUM BETA-LACTAMASE, UNP RESIDUES 29-291; COMPND 5 SYNONYM: BETA-LACTAMASE CTX-M, BETA-LACTAMASE CTX-M-9A, BETALACTAMASE COMPND 6 CTX-M-9, CTX-M-9 BETA-LACTAMASE, CTX-M-9 EXTENDED-SPECTRUM BETA- COMPND 7 LACTAMASE; COMPND 8 EC: 3.5.2.6; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: BLACTX-M-9, BLACTX-M-9A, BLACTX-M-9B; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-9A KEYWDS BETA-LACTAMASE, ESBL, CTX-M, CTX-M-9, BETA-LACTAM, PIPERACILLIN, KEYWDS 2 MICHAELIS, ANTIBIOTIC RESISTANCE, HYDROLASE, ALPHA BETA FOLD, KEYWDS 3 HYDROLASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.LEYSSNE,J.DELMAS,A.COIGNOUX,F.ROBIN,R.BONNET REVDAT 2 01-NOV-23 3Q1F 1 REMARK SEQADV REVDAT 1 21-DEC-11 3Q1F 0 JRNL AUTH D.LEYSSNE,J.DELMAS,A.COIGNOUX,F.ROBIN,R.BONNET JRNL TITL CTX-M-9 S70G MUTANT IN COMPLEX WITH HYDROLYZED PIPERACILLIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 66447 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.176 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3441 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4853 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.49 REMARK 3 BIN R VALUE (WORKING SET) : 0.1420 REMARK 3 BIN FREE R VALUE SET COUNT : 254 REMARK 3 BIN FREE R VALUE : 0.1780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 751 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.074 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4333 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5961 ; 1.301 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 582 ; 3.882 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;40.183 ;24.773 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 704 ;13.176 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;15.538 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 692 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4028 ; 0.018 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2300 ; 0.221 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3113 ; 0.315 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 1063 ; 0.189 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 105 ; 0.251 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 145 ; 0.193 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2751 ; 1.650 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4454 ; 2.429 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1582 ; 2.721 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1486 ; 4.150 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3Q1F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063073. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0723 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 135290 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.37500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2P74 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M PHOSPHATE, PH 8.2, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.30300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 26 REMARK 465 GLN B 26 REMARK 465 THR B 27 REMARK 465 SER B 28 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -138.26 49.68 REMARK 500 VAL A 103 -135.40 -115.93 REMARK 500 SER A 220 -132.75 -104.51 REMARK 500 CYS B 69 -137.28 48.37 REMARK 500 VAL B 103 -140.06 -113.09 REMARK 500 SER B 220 -134.95 -104.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YPP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YPP A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YPP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YPP B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HRE RELATED DB: PDB REMARK 900 X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 S70G REMARK 900 RELATED ID: 3HLW RELATED DB: PDB REMARK 900 CTX-M-9 S70G IN COMPLEX WITH CEFOTAXIME REMARK 900 RELATED ID: 3HUO RELATED DB: PDB REMARK 900 CTX-M-9 S70G IN COMPLEX WITH BENZYLPENICILLIN REMARK 900 RELATED ID: 3HVF RELATED DB: PDB REMARK 900 CTX-M-9 S70G IN COMPLEX WITH HYDROLYZED BENZYLPENICILLIN REMARK 900 RELATED ID: 2P74 RELATED DB: PDB REMARK 900 CTX-M-9 CLASS A BETA-LACTAMASE APO CRYSTAL STRUCTURE AT 0.88 REMARK 900 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 3Q07 RELATED DB: PDB REMARK 900 CTX-M-9 S70G MUTANT IN COMPLEX WITH PIPERACILLIN DBREF 3Q1F A 26 288 UNP Q9L5C8 Q9L5C8_ECOLX 29 291 DBREF 3Q1F B 26 288 UNP Q9L5C8 Q9L5C8_ECOLX 29 291 SEQADV 3Q1F GLY A 70 UNP Q9L5C8 SER 73 ENGINEERED MUTATION SEQADV 3Q1F GLY B 70 UNP Q9L5C8 SER 73 ENGINEERED MUTATION SEQRES 1 A 263 GLN THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU SEQRES 2 A 263 LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP SEQRES 3 A 263 THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU SEQRES 4 A 263 ARG PHE PRO MET CYS GLY THR SER LYS VAL MET ALA ALA SEQRES 5 A 263 ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU SEQRES 6 A 263 LEU ASN GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL SEQRES 7 A 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 A 263 MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 A 263 SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU SEQRES 10 A 263 GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE SEQRES 11 A 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 A 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 A 263 THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR SEQRES 14 A 263 LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU SEQRES 15 A 263 VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 A 263 ILE ARG ALA GLY LEU PRO THR SER TRP THR ALA GLY ASP SEQRES 17 A 263 LYS THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE SEQRES 18 A 263 ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU SEQRES 19 A 263 VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER SEQRES 20 A 263 ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA SEQRES 21 A 263 GLU GLY LEU SEQRES 1 B 263 GLN THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU SEQRES 2 B 263 LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP SEQRES 3 B 263 THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU SEQRES 4 B 263 ARG PHE PRO MET CYS GLY THR SER LYS VAL MET ALA ALA SEQRES 5 B 263 ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU SEQRES 6 B 263 LEU ASN GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL SEQRES 7 B 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 B 263 MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 B 263 SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU SEQRES 10 B 263 GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE SEQRES 11 B 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 B 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 B 263 THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR SEQRES 14 B 263 LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU SEQRES 15 B 263 VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 B 263 ILE ARG ALA GLY LEU PRO THR SER TRP THR ALA GLY ASP SEQRES 17 B 263 LYS THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE SEQRES 18 B 263 ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU SEQRES 19 B 263 VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER SEQRES 20 B 263 ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA SEQRES 21 B 263 GLU GLY LEU HET YPP A 301 37 HET YPP A 302 37 HET YPP B 301 37 HET YPP B 302 37 HETNAM YPP HYDROLYZED PIPERACILLIN HETSYN YPP (2R,4S)-2-[(R)-CARBOXY{[(2R)-2-{[(4-ETHYL-2,3- HETSYN 2 YPP DIOXOPIPERAZIN-1-YL)CARBONYL]AMINO}-2- HETSYN 3 YPP PHENYLACETYL]AMINO}METHYL]-5,5-DIMETHYL-1,3- HETSYN 4 YPP THIAZOLIDINE-4-CARBOXYLIC ACID FORMUL 3 YPP 4(C23 H29 N5 O8 S) FORMUL 7 HOH *751(H2 O) HELIX 1 1 SER A 28 GLY A 42 1 15 HELIX 2 2 THR A 71 GLU A 85 1 15 HELIX 3 3 GLN A 89 ASN A 92 5 4 HELIX 4 4 LYS A 98 LEU A 102 5 5 HELIX 5 5 ILE A 108 VAL A 113 5 6 HELIX 6 6 LEU A 119 SER A 130 1 12 HELIX 7 7 ASP A 131 LEU A 142 1 12 HELIX 8 8 GLY A 144 ILE A 155 1 12 HELIX 9 9 PRO A 167 THR A 171 5 5 HELIX 10 10 THR A 182 LEU A 195 1 14 HELIX 11 11 GLY A 200 GLY A 213 1 14 HELIX 12 12 SER A 220 LEU A 225 5 6 HELIX 13 13 ARG A 273 GLY A 287 1 15 HELIX 14 14 ALA B 29 GLY B 42 1 14 HELIX 15 15 CYS B 69 THR B 71 5 3 HELIX 16 16 SER B 72 GLU B 85 1 14 HELIX 17 17 GLN B 89 ASN B 92 5 4 HELIX 18 18 LYS B 98 LEU B 102 5 5 HELIX 19 19 ILE B 108 VAL B 113 5 6 HELIX 20 20 LEU B 119 SER B 130 1 12 HELIX 21 21 ASP B 131 LEU B 142 1 12 HELIX 22 22 GLY B 144 ILE B 155 1 12 HELIX 23 23 PRO B 167 THR B 171 5 5 HELIX 24 24 THR B 182 GLY B 196 1 15 HELIX 25 25 GLY B 200 GLY B 213 1 14 HELIX 26 26 SER B 220 LEU B 225 5 6 HELIX 27 27 ARG B 273 GLY B 287 1 15 SHEET 1 A 5 GLN A 57 TYR A 60 0 SHEET 2 A 5 ARG A 44 ASP A 51 -1 N VAL A 47 O TYR A 60 SHEET 3 A 5 LEU A 257 THR A 264 -1 O THR A 264 N ARG A 44 SHEET 4 A 5 THR A 242 TRP A 250 -1 N ILE A 249 O LEU A 257 SHEET 5 A 5 THR A 230 GLY A 238 -1 N THR A 230 O TRP A 250 SHEET 1 B 2 PHE A 66 PRO A 67 0 SHEET 2 B 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 C 2 PRO A 94 ILE A 97 0 SHEET 2 C 2 GLY A 115 THR A 118 -1 O GLY A 115 N ILE A 97 SHEET 1 D 5 GLN B 57 TYR B 60 0 SHEET 2 D 5 ARG B 44 ASP B 51 -1 N LEU B 49 O VAL B 58 SHEET 3 D 5 LEU B 257 THR B 264 -1 O TYR B 262 N GLY B 46 SHEET 4 D 5 THR B 242 TRP B 250 -1 N ALA B 247 O LEU B 259 SHEET 5 D 5 THR B 230 GLY B 238 -1 N THR B 230 O TRP B 250 SHEET 1 E 2 PHE B 66 PRO B 67 0 SHEET 2 E 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 F 2 PRO B 94 ILE B 97 0 SHEET 2 F 2 GLY B 115 THR B 118 -1 O GLY B 115 N ILE B 97 CISPEP 1 GLU A 166 PRO A 167 0 3.39 CISPEP 2 GLU B 166 PRO B 167 0 7.94 SITE 1 AC1 21 HOH A 23 CYS A 69 GLY A 70 LYS A 73 SITE 2 AC1 21 ASN A 104 TYR A 105 SER A 130 ASN A 132 SITE 3 AC1 21 PRO A 167 THR A 168 ASN A 170 GLY A 236 SITE 4 AC1 21 SER A 237 GLY A 238 ASP A 239 ARG A 254 SITE 5 AC1 21 HOH A 377 HOH A 417 HOH A 490 HOH A 540 SITE 6 AC1 21 HOH A 549 SITE 1 AC2 20 GLN A 32 LYS A 39 LYS A 82 GLN A 83 SITE 2 AC2 20 ALA A 150 ALA A 154 HOH A 297 HOH A 328 SITE 3 AC2 20 HOH A 370 HOH A 385 HOH A 397 HOH A 503 SITE 4 AC2 20 HOH A 566 HOH A 663 HOH A 664 HOH A 680 SITE 5 AC2 20 HOH A 731 ASP B 54 ASN B 55 ARG B 178 SITE 1 AC3 20 CYS B 69 GLY B 70 LYS B 73 ASN B 104 SITE 2 AC3 20 TYR B 105 SER B 130 ASN B 132 PRO B 167 SITE 3 AC3 20 THR B 168 ASN B 170 GLY B 236 SER B 237 SITE 4 AC3 20 GLY B 238 ASP B 239 ARG B 254 HOH B 454 SITE 5 AC3 20 HOH B 505 HOH B 582 HOH B 617 HOH B 620 SITE 1 AC4 13 GLU A 158 HOH A 550 ALA B 100 THR B 194 SITE 2 AC4 13 LEU B 195 ARG B 204 LYS B 212 THR B 230 SITE 3 AC4 13 TRP B 250 PRO B 256 HOH B 366 HOH B 518 SITE 4 AC4 13 HOH B 613 CRYST1 45.098 106.606 47.541 90.00 101.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022174 0.000000 0.004679 0.00000 SCALE2 0.000000 0.009380 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021498 0.00000